Fore Biotherapeutics
Signal active
Organization
Contact Information
Overview
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics. The company is creating a pipeline of precision oncology treatments aimed at patients with unaddressed mutations across well-established oncology targets.
About
Industries
Biotechnology, Health Care, Medical, Health Diagnostics, Oncology
Founded
2011
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Fore Biotherapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Health Diagnostics, Oncology sector. The company focuses on Biotechnology and has secured $30.0B in funding across 180 round(s). With a team of 11-50 employees, Fore Biotherapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Fore Biotherapeutics, raised $8.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
9
Investors
0
Lead Investors
0
Total Funding Amount
$166.5M
Details
5
Fore Biotherapeutics has raised a total of $166.5M in funding over 5 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Late Stage Venture | |||
| 2023 | Late Stage Venture | 75.0M | ||
| 2014 | Seed | 8.0M | ||
| 2013 | Seed | 8.0M |
Investors
Fore Biotherapeutics is funded by 38 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| HBM Partners | - | FUNDING ROUND - HBM Partners | 75.0M |
| Fore Biotherapeutics | - | FUNDING ROUND - Fore Biotherapeutics | 2.5M |
| OrbiMed | - | FUNDING ROUND - OrbiMed | 2.5M |
| Fore Biotherapeutics | - | FUNDING ROUND - Fore Biotherapeutics | 10.0M |
Recent Activity
There is no recent news or activity for this profile.